Axogen, Inc. (AXGN) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 30.37M USD | Liabilities, Current |
| Cash and equivalents | 94.57M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 34.13M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 47.31M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $30.37M | $94.57M | (m) | $34.13M | $47.31M | (m) |
| 2026-03-31 | (m) | $26.01M | $82.65M | (m) | $28.31M | $46.07M | (m) |
| 2025-12-31 | (m) | $23.56M | $35.55M | (m) | $26.17M | $42.37M | (m) |
| 2025-09-30 | (m) | $28.01M | $23.90M | (m) | $30.77M | $40.58M | (m) |
| 2025-06-30 | (m) | $24.98M | $20.04M | (m) | $28.03M | $36.77M | (m) |
| 2025-03-31 | (m) | $21.75M | $18.10M | (m) | $26.30M | $35.50M | (m) |
| 2024-12-31 | (m) | $30.61M | $27.55M | (m) | $24.11M | $33.18M | (m) |
| 2024-09-30 | (m) | $23.03M | $18.66M | (m) | $24.63M | $29.36M | (m) |
| 2024-06-30 | (m) | $23.41M | $19.19M | (m) | $25.15M | $28.02M | (m) |
| 2024-03-31 | (m) | $22.93M | $15.71M | (m) | $24.21M | $27.64M | (m) |
| 2023-12-31 | (m) | $30.43M | $31.02M | (m) | $25.15M | $23.02M | (m) |
| 2023-09-30 | (m) | $26.65M | $31.09M | (m) | $23.26M | $23.02M | (m) |
| 2023-06-30 | (m) | $23.93M | $23.22M | (m) | $21.57M | $21.24M | (m) |
| 2023-03-31 | (m) | $21.24M | $7.71M | (m) | $22.28M | $19.85M | (m) |
| 2022-12-31 | (m) | $23.75M | $15.28M | (m) | $22.19M | $18.91M | (m) |
| 2022-09-30 | (m) | $23.55M | $14.32M | (m) | $21.36M | $19.12M | (m) |
| 2022-06-30 | (m) | $23.60M | $11.82M | (m) | $20.37M | $19.22M | (m) |
| 2022-03-31 | (m) | $22.95M | $14.56M | (m) | $18.59M | $17.40M | (m) |
| 2021-12-31 | (m) | $24.29M | $32.76M | (m) | $18.16M | $16.69M | (m) |
| 2021-09-30 | (m) | $23.36M | $46.73M | (m) | $18.57M | $15.45M | (m) |
| 2021-06-30 | (m) | $21.63M | $53.08M | (m) | $18.18M | $13.41M | (m) |
| 2021-03-31 | (m) | $22.27M | $39.84M | (m) | $19.82M | $13.39M | (m) |
| 2020-12-31 | (m) | $22.83M | $48.77M | (m) | $17.62M | $12.53M | (m) |
| 2020-09-30 | (m) | $18.79M | $60.00M | (m) | $18.76M | $11.93M | (m) |
| 2020-06-30 | (m) | $14.02M | $75.32M | (m) | $14.05M | $12.84M | (m) |
| 2020-03-31 | (m) | $19.49M | $35.89M | (m) | $13.02M | $14.56M | (m) |
| 2019-12-31 | (m) | $20.88M | $35.72M | (m) | $16.94M | $13.86M | (m) |
| 2019-09-30 | (m) | $16.76M | $24.55M | (m) | $15.45M | $13.68M | (m) |
| 2019-06-30 | (m) | $16.23M | $24.88M | (m) | $16.29M | $13.59M | (m) |
| 2019-03-31 | (m) | $16.49M | $23.52M | (m) | $15.19M | $13.12M | (m) |
| 2018-12-31 | (m) | $13.04M | $24.29M | (m) | $15.32M | $11.98M | (m) |
| 2018-09-30 | (m) | $12.02M | $25.63M | (m) | $13.99M | $10.95M | (m) |
| 2018-06-30 | (m) | $9.86M | $133.56M | (m) | $12.36M | $9.68M | (m) |
| 2018-03-31 | (m) | $15.57M | $30.56M | (m) | $11.77M | $8.05M | (m) |
| 2017-12-31 | (m) | $13.72M | $36.51M | (m) | $11.06M | $7.32M | (m) |
| 2017-09-30 | (m) | $11.14M | $22.04M | (m) | $10.20M | $6.70M | (m) |
| 2017-06-30 | (m) | $10.95M | $23.87M | (m) | $9.42M | $6.30M | (m) |
| 2017-03-31 | (m) | $10.69M | $25.91M | (m) | $8.38M | $5.85M | (m) |
| 2016-12-31 | (m) | $11.08M | $30.01M | (m) | $8.05M | $5.46M | (m) |
| 2016-09-30 | (m) | $4.60M | $16.00M | (m) | $7.00M | $4.97M | (m) |
| 2016-06-30 | (m) | $3.92M | $18.27M | (m) | $6.07M | $4.79M | (m) |
| 2016-03-31 | (m) | $3.76M | $20.95M | (m) | $5.29M | $4.52M | (m) |
| 2015-12-31 | (m) | $3.71M | $25.91M | (m) | $4.78M | $3.93M | (m) |
| 2015-09-30 | (m) | $4.10M | $29.94M | (m) | $4.64M | $3.70M | (m) |
| 2015-06-30 | (m) | $3.42M | $15.62M | (m) | $3.84M | $3.54M | (m) |
| 2015-03-31 | (m) | $3.44M | $19.26M | (m) | $3.16M | $3.34M | (m) |
| 2014-12-31 | (m) | $2.45M | $8.22M | (m) | $2.87M | $3.21M | (m) |
| 2014-09-30 | (m) | $2.03M | $11.80M | (m) | $2.74M | $3.35M | (m) |
| 2014-06-30 | (m) | $2.25M | $14.17M | (m) | $2.53M | $3.41M | (m) |
| 2014-03-31 | (m) | $1.92M | $16.81M | (m) | $1.97M | $3.47M | (m) |
| 2013-12-31 | (m) | $2.10M | $20.07M | (m) | $1.89M | $3.40M | (m) |
| 2013-09-30 | (m) | $1.32M | $22.59M | (m) | $1.74M | $3.46M | (m) |
| 2013-06-30 | (m) | $1.59M | $8.69M | (m) | $1.42M | $3.58M | (m) |
| 2013-03-31 | (m) | $1.42M | $11.20M | (m) | $1.18M | $3.42M | (m) |
| 2012-12-31 | (m) | $1.48M | $13.91M | (m) | $1.05M | $3.15M | (m) |
| 2012-09-30 | (m) | $3.75M | $4.45M | (m) | $925.54K | $2.72M | (m) |
| 2012-06-30 | (m) | $3.11M | $4.64M | (m) | $862.23K | $2.47M | (m) |
| 2012-03-31 | (m) | $2.42M | $5.64M | (m) | $893.98K | $2.13M | (m) |
| 2011-12-31 | (m) | $2.02M | $8.19M | (m) | $797.65K | $1.76M | (m) |
| 2011-09-30 | (m) | $1.66M | $10.53M | (m) | $538.11K | $1.66M | (m) |
| 2011-06-30 | (m) | $611.57K | $7.84M | (m) | $19.11K | (m) | (m) |
| 2011-03-31 | (m) | (m) | $586.74K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $114.35K | $7.08M | (m) | $42.12K | (m) | (m) |
| 2010-09-30 | (m) | (m) | $207.33K | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $9.63M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $15.77M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |